These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 35988295)

  • 21. Development of Pan-Anti-SARS-CoV-2 Agents through Allosteric Inhibition of nsp14/nsp10 Complex.
    Chen J; Zhou Y; Wei X; Xu X; Qin Z; Ong CP; Ye ZW; Jin DY; Boitrel B; Yuan S; Chan JF; Li H; Sun H
    ACS Infect Dis; 2024 Mar; 10(3):858-869. PubMed ID: 37897418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A universal fluorescence polarization high throughput screening assay to target the SAM-binding sites of SARS-CoV-2 and other viral methyltransferases.
    Samrat SK; Bashir Q; Zhang R; Huang Y; Liu Y; Wu X; Brown T; Wang W; Zheng YG; Zhang QY; Chen Y; Li Z; Li H
    Emerg Microbes Infect; 2023 Dec; 12(1):2204164. PubMed ID: 37060263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ritonavir may inhibit exoribonuclease activity of nsp14 from the SARS-CoV-2 virus and potentiate the activity of chain terminating drugs.
    Narayanan N; Nair DT
    Int J Biol Macromol; 2021 Jan; 168():272-278. PubMed ID: 33309661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A High-Throughput Radioactivity-Based Assay for Screening SARS-CoV-2 nsp10-nsp16 Complex.
    Khalili Yazdi A; Li F; Devkota K; Perveen S; Ghiabi P; Hajian T; Bolotokova A; Vedadi M
    SLAS Discov; 2021 Jul; 26(6):757-765. PubMed ID: 33874769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the SARS-CoV-2 ExoN (nsp14ExoN-nsp10) complex: implications for its role in viral genome stability and inhibitor identification.
    Baddock HT; Brolih S; Yosaatmadja Y; Ratnaweera M; Bielinski M; Swift LP; Cruz-Migoni A; Fan H; Keown JR; Walker AP; Morris GM; Grimes JM; Fodor E; Schofield CJ; Gileadi O; McHugh PJ
    Nucleic Acids Res; 2022 Feb; 50(3):1484-1500. PubMed ID: 35037045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coronavirus Nsp10, a critical co-factor for activation of multiple replicative enzymes.
    Bouvet M; Lugari A; Posthuma CC; Zevenhoven JC; Bernard S; Betzi S; Imbert I; Canard B; Guillemot JC; Lécine P; Pfefferle S; Drosten C; Snijder EJ; Decroly E; Morelli X
    J Biol Chem; 2014 Sep; 289(37):25783-96. PubMed ID: 25074927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of the SARS-CoV-2 NSP14 3'-5' exoribonuclease by NSP10 and response to antiviral inhibitors.
    Riccio AA; Sullivan ED; Copeland WC
    J Biol Chem; 2022 Jan; 298(1):101518. PubMed ID: 34942146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utilization of the EpiMed Coronabank Chemical Collection to identify potential SARS-CoV-2 antivirals: in silico studies targeting the nsp14 ExoN domain and PL
    Liang JJ; Pitsillou E; Lau HLY; Mccubbery CP; Gan H; Hung A; Karagiannis TC
    J Mol Graph Model; 2024 Sep; 131():108803. PubMed ID: 38815531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computational Analysis of SAM Analogs as Methyltransferase Inhibitors of nsp16/nsp10 Complex from SARS-CoV-2.
    Balieiro AM; Anunciação ELS; Costa CHS; Qayed WS; Silva JRA
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular Interactions of Zyesami with the SARS-CoV-2 nsp10/nsp16 Protein Complex.
    Alnomasy SF; Alotaibi BS; Aldosari ZM; Mujamammi AH; Alzamami A; Anand P; Akhter Y; Khan FR; Hasan MR
    Comb Chem High Throughput Screen; 2023; 26(6):1196-1203. PubMed ID: 35975856
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Maurya AK; Mishra N
    J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In silico identification of novel SARS-COV-2 2'-O-methyltransferase (nsp16) inhibitors: structure-based virtual screening, molecular dynamics simulation and MM-PBSA approaches.
    El Hassab MA; Ibrahim TM; Al-Rashood ST; Alharbi A; Eskandrani RO; Eldehna WM
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):727-736. PubMed ID: 33685335
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Chandra A; Chaudhary M; Qamar I; Singh N; Nain V
    J Biomol Struct Dyn; 2022 Sep; 40(14):6534-6544. PubMed ID: 33583328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular dynamic simulations reveal anti-SARS-CoV-2 activity of mitocurcumin by potentially blocking innate immune evasion proteins NSP3 and NSP16.
    Pal D; Checker R; Kutala VK; Sandur SK
    Mol Divers; 2023 Apr; 27(2):635-649. PubMed ID: 35538380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ligand and Structure-Based In Silico Determination of the Most Promising SARS-CoV-2 nsp16-nsp10 2'-
    Eissa IH; Alesawy MS; Saleh AM; Elkaeed EB; Alsfouk BA; El-Attar AMM; Metwaly AM
    Molecules; 2022 Mar; 27(7):. PubMed ID: 35408684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Refolding of lid subdomain of SARS-CoV-2 nsp14 upon nsp10 interaction releases exonuclease activity.
    Czarna A; Plewka J; Kresik L; Matsuda A; Karim A; Robinson C; O'Byrne S; Cunningham F; Georgiou I; Wilk P; Pachota M; Popowicz G; Wyatt PG; Dubin G; Pyrć K
    Structure; 2022 Aug; 30(8):1050-1054.e2. PubMed ID: 35609600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting SARS-CoV-2 main protease: structure based virtual screening, in silico ADMET studies and molecular dynamics simulation for identification of potential inhibitors.
    Uniyal A; Mahapatra MK; Tiwari V; Sandhir R; Kumar R
    J Biomol Struct Dyn; 2022 May; 40(8):3609-3625. PubMed ID: 33226303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential Drugs Targeting Early Innate Immune Evasion of SARS-Coronavirus 2 via 2'-O-Methylation of Viral RNA.
    Encinar JA; Menendez JA
    Viruses; 2020 May; 12(5):. PubMed ID: 32397643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploration of Novel Lichen Compounds as Inhibitors of SARS-CoV-2 Mpro: Ligand-Based Design, Molecular Dynamics, and ADMET Analyses.
    Gupta A; Sahu N; Singh AP; Singh VK; Singh SC; Upadhye VJ; Mathew AT; Kumar R; Sinha RP
    Appl Biochem Biotechnol; 2022 Dec; 194(12):6386-6406. PubMed ID: 35921031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and structural studies of natural inhibitors against SARS-CoV-2 viral RNA methyltransferase (NSP16).
    Kumar M; Roy A; Rawat RS; Alok A; Tetala KKR; Biswas NR; Kaur P; Kumar S
    J Biomol Struct Dyn; 2022; 40(24):13965-13975. PubMed ID: 34766876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.